Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.

Horai Y, Utsumi H, Ono Y, Kishimoto T, Ono Y, Fukunari A.

Int J Exp Pathol. 2016 Feb;97(1):75-85. doi: 10.1111/iep.12169. Epub 2016 Mar 31.

2.

IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.

Maeda Y, Seki N, Kataoka H, Takemoto K, Utsumi H, Fukunari A, Sugahara K, Chiba K.

J Immunol. 2015 Aug 15;195(4):1408-16. doi: 10.4049/jimmunol.1500599. Epub 2015 Jul 13.

3.

Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.

Kakimoto T, Okada K, Fujitaka K, Nishio M, Kato T, Fukunari A, Utsumi H.

Exp Toxicol Pathol. 2015 Feb;67(2):171-7. doi: 10.1016/j.etp.2014.11.007. Epub 2014 Dec 4.

PMID:
25481214
4.

Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.

Kakimoto T, Okada K, Hirohashi Y, Relator R, Kawai M, Iguchi T, Fujitaka K, Nishio M, Kato T, Fukunari A, Utsumi H.

J Endocrinol. 2014 Jul;222(1):43-51. doi: 10.1530/JOE-14-0164. Epub 2014 Apr 29.

PMID:
24781258
5.

S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.

Maeda Y, Yagi H, Takemoto K, Utsumi H, Fukunari A, Sugahara K, Masuko T, Chiba K.

Int Immunol. 2014 May;26(5):245-55. doi: 10.1093/intimm/dxt069. Epub 2013 Dec 16.

PMID:
24343820
6.

Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.

Tezuka T, Tamura M, Kondo MA, Sakaue M, Okada K, Takemoto K, Fukunari A, Miwa K, Ohzeki H, Kano S, Yasumatsu H, Sawa A, Kajii Y.

Neurobiol Dis. 2013 Nov;59:63-8. doi: 10.1016/j.nbd.2013.07.003. Epub 2013 Jul 16.

7.

[Cuprizone early deficits accompanied by specific glial activation implicate pathophysiological changes in schizophrenia].

Tezuka T, Tamura M, Kondo MA, Sakaue M, Okada K, Takemoto K, Fukunari A, Yasumatsu H, Kajii Y.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Apr;33(2):65-6. Japanese. No abstract available.

PMID:
25314741
8.

Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.

Kakimoto T, Kimata H, Iwasaki S, Fukunari A, Utsumi H.

J Endocrinol. 2013 Jan 2;216(1):13-20. doi: 10.1530/JOE-12-0456. Print 2013 Jan.

PMID:
23092878
9.

Expression of vascular endothelial growth factor (VEGF) associated with histopathological changes in rodent models of osteoarthritis.

Yamairi F, Utsumi H, Ono Y, Komorita N, Tanaka M, Fukunari A.

J Toxicol Pathol. 2011 Jun;24(2):137-42. doi: 10.1293/tox.24.137. Epub 2011 Jun 30.

10.

Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.

Chiba K, Kataoka H, Seki N, Shimano K, Koyama M, Fukunari A, Sugahara K, Sugita T.

Int Immunopharmacol. 2011 Mar;11(3):366-72. doi: 10.1016/j.intimp.2010.10.005. Epub 2010 Oct 16.

PMID:
20955831
11.

Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.

Noguchi A, Matsumura S, Dezawa M, Tada M, Yanazawa M, Ito A, Akioka M, Kikuchi S, Sato M, Ideno S, Noda M, Fukunari A, Muramatsu S, Itokazu Y, Sato K, Takahashi H, Teplow DB, Nabeshima Y, Kakita A, Imahori K, Hoshi M.

J Biol Chem. 2009 Nov 20;284(47):32895-905. doi: 10.1074/jbc.M109.000208. Epub 2009 Sep 15.

12.

Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.

Ishizaki K, Iwaki T, Kinoshita S, Koyama M, Fukunari A, Tanaka H, Tsurufuji M, Sakata K, Maeda Y, Imada T, Chiba K.

Eur J Pharmacol. 2008 Jan 6;578(1):57-64. Epub 2007 Sep 4.

PMID:
17888421
13.

Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.

Iwaki T, Ishizaki K, Kinoshita S, Tanaka H, Fukunari A, Tsurufuji M, Imada T.

World J Gastroenterol. 2007 Oct 7;13(37):5003-8.

14.

Hemostatic action of OC-108, a novel agent for hemorrhoids, is associated with regional blood flow arrest induced by acute inflammation.

Ono T, Nakagawa H, Fukunari A, Hashimoto T, Komatsu H.

J Pharmacol Sci. 2006 Nov;102(3):314-20. Epub 2006 Oct 28.

15.

FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.

Kataoka H, Sugahara K, Shimano K, Teshima K, Koyama M, Fukunari A, Chiba K.

Cell Mol Immunol. 2005 Dec;2(6):439-48.

16.
17.

Pharmacokinetics/pharmacodynamics of Y-700, a novel xanthine oxidase inhibitor, in rats and man.

Yamada I, Fukunari A, Osajima T, Kamezawa M, Mori H, Iwane J.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1123-5.

PMID:
15571214
18.

The mechanism of inhibition by xanthine of adenosine A1-receptor responses in rat hippocampus.

Shahraki A, Fukunari A, Stone TW.

Neurosci Lett. 2004 Jul 29;365(3):162-6.

PMID:
15246540
19.

Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion.

Fukunari A, Okamoto K, Nishino T, Eger BT, Pai EF, Kamezawa M, Yamada I, Kato N.

J Pharmacol Exp Ther. 2004 Nov;311(2):519-28. Epub 2004 Jun 9.

PMID:
15190124
20.

Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in rats.

Kobayashi K, Imaizumi R, Sumichika H, Tanaka H, Goda M, Fukunari A, Komatsu H.

J Vet Med Sci. 2003 Nov;65(11):1195-9.

PMID:
14665748
21.

Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.

Ishibuchi S, Morimoto H, Oe T, Ikebe T, Inoue H, Fukunari A, Kamezawa M, Yamada I, Naka Y.

Bioorg Med Chem Lett. 2001 Apr 9;11(7):879-82.

PMID:
11294382
22.
23.

Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse.

Kato A, Fukunari A, Sakai Y, Nakajima T.

J Pharmacol Exp Ther. 1997 Oct;283(1):328-35.

PMID:
9336340
24.

Y-26763 protects the canine heart from a stunning injury through opening of the KATP channels.

Fukunari A, Miyai H, Shinagawa K, Kawahara K, Nakajima T.

Eur J Pharmacol. 1997 Apr 4;323(2-3):197-204.

PMID:
9128839
25.

Colocalization of prolyl endopeptidase and amyloid beta-peptide in brains of senescence-accelerated mouse.

Fukunari A, Kato A, Sakai Y, Yoshimoto T, Ishiura S, Suzuki K, Nakajima T.

Neurosci Lett. 1994 Aug 1;176(2):201-4.

PMID:
7830947
26.

Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.

Nakajima T, Shinohara T, Yaoka O, Fukunari A, Shinagawa K, Aoki K, Katoh A, Yamanaka T, Setoguchi M, Tahara T.

J Pharmacol Exp Ther. 1992 May;261(2):730-6.

PMID:
1578381

Supplemental Content

Loading ...
Support Center